MemoProve Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: Vendor-neutral scientific reference catalog entry for MemoProve/N-PEP-12.

Proprietary peptide-based nutritional supplement compound Reference needs_revision Best effort · source review pending

Also known as: MemoProve®, N-PEP-12, N-Pep-12, Cebrium®

Open in Calculator ← Compound Index All Tools

Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.

Quick Facts

Reference Sizes

Not standardized / source review pending

Components

N-PEP-12: heterogeneous mixture of low-molecular-weight peptides and free amino acids derived from standardized enzymatic proteolysis of purified porcine brain proteins + Lactose monohydrate carrier and pharmaceutical excipients

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component

N-PEP-12: heterogeneous mixture of low-molecular-weight peptides and free amino acids derived from standardized enzymatic proteolysis of purified porcine brain proteins

Calculator Profile

Component

Lactose monohydrate carrier and pharmaceutical excipients

Calculator Profile

Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Best-Effort Research Profile

MemoProve is the product name used for N-PEP-12, a peptide-based nutritional supplement associated with EVER Neuro Pharma. Authoritative study reporting describes N-PEP-12 as a proprietary preparation produced by standardized enzymatic proteolysis of purified porcine brain proteins. Its detailed peptide composition, molecular-weight distribution, and quality-control specifications were not disclosed in the published clinical study. ([mdpi.com](https://www.mdpi.com/2072-6643/18/16/2739?utm_source=openai))

Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.

Research Profile

Administration Routes (Research)

oral

Reported Research Effects

In a randomized placebo-controlled study in healthy older adults with subjective cognitive complaints, N-PEP-12 was evaluated for attention, working memory, mental wellbeing, sleep quality, and related outcomes; the authors characterized several findings as exploratory and stated that further research is needed. ([mdpi.com](https://www.mdpi.com/2072-6643/18/16/2739?utm_source=openai))
A prior human study reported changes in EEG alpha and delta activity and improvement in some memory-performance subtests 6 hours after a single oral 180 mg dose; the authors described the findings as warranting further investigation. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16258593/?utm_source=openai))

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Notes

Published study regimens include a single oral 180 mg dose with assessments 6 hours after administration, daily oral 45 mg or 90 mg doses assessed over 30, 90, and 180 days, and a registered 90 mg once-daily oral regimen for 360 days after ischemic stroke. These are study/reference regimens only and are not prescribing or individualized-use recommendations. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16258593/?utm_source=openai))

Supplementary research context only. Not medical advice or a treatment recommendation.

Registry Identifiers

N-PEP-12; no CAS Registry Number, UNII, molecular formula, or single defined molecular structure was identified in the authoritative sources reviewed.

Source-Backed Observations

MemoProve/N-PEP-12 should be cataloged as a proprietary peptide mixture or preparation, not as a single pure compound. Published research identifies MemoProve and Cebrium as brands of N-PEP-12. ([mdpi.com](https://www.mdpi.com/2072-6643/18/16/2739?utm_source=openai))

Reflects published research. Educational reference — not a recommendation for use.

Sources Under Review

Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjects
https://pubmed.ncbi.nlm.nih.gov/16258593/ (accessed 2026-09-13)

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Blend CalculatorPre-filled with all blend components Unit Convertermg, mcg, mL, units conversion Compound CompareSide-by-side comparison tool Cost CalculatorCost per mg, mcg, per-draw

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.